Brief: InspireMD Appoints Principal Investigators for C-GUARDIANS II Clinical Trial of the SwitchGuard Neuroprotection System
12/02/2024 12:40
Feb 12 (Reuters) - InspireMD Inc NSPR.O :
* INSPIREMD APPOINTS PRINCIPAL INVESTIGATORS FOR C-GUARDIANS
II
CLINICAL TRIAL OF THE SWITCHGUARD™ NEUROPROTECTION SYSTEM
Source text for Eikon: ID:nGNXbvZvD6
Further company coverage: NSPR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on InspireMD
See all newsInspireMD Inc reports results for the quarter ended June 30 - Earnings Summary
InspireMD Q2 revenue beats estimates on international demand
InspireMD Inc expected to post a loss of 20 cents a share - Earnings Preview
InspireMD Inc expected to post a loss of 20 cents a share - Earnings Preview
InspireMD Q1 revenue jumps 122%, beats estimates on product demand